Cite
HARVARD Citation
Buti, M. et al. (2017). Cost‐effectiveness analysis of ledipasvir/sofosbuvir in patients with chronic hepatitis C: Treatment of patients with absence or mild fibrosis compared to patients with advanced fibrosis. Journal of viral hepatitis. 24 (9), pp. 750-758. [Online].